Table 1.
Number of Patients | Gender (Females/Males) (n) | Age (Mean ± SD) | |
---|---|---|---|
Total knee replacements | |||
TXA (Group A) | 83 | 69/14 | 71.3 ± 5.7 |
TXA + vancomycin (Group B) | 83 | 66/17 | 70.3 ± 7.6 |
Control (Group C) | 93 | 76/17 | 70.5 ± 5.5 |
Chi square test, p = 0.565 | ANOVA test, p = 0.556 | ||
Total hip replacements | |||
TXA (Group A) | 65 | 42/23 | 64 ± 12.5 |
TXA + vancomycin (Group B) | 59 | 35/24 | 62.1 ± 11.9 |
Control (Group C) | 85 | 52/33 | 62.5 ± 11.3 |
Chi square test, p = 0.332 | ANOVA test, p = 0.631 |